Filter posts

Meet Opiant’s Roger Crystal, Fireside Chat Speaker at #BIOCEO19

When pop star Demi Lovato experienced an apparent opioid-related overdose last summer, reports stated that …

It Starts with One—Partnering Meeting Leads to Unique Public-Private Partnership

Roy Zwahlen took a long shot when he requested a meeting with an investment firm …

Patient Groups/Industry Address Best Practices to Avoid Conflicts

At a recent panel discussion at BIO’s Patient and Health Advocacy Summit, representatives from biopharmaceutical …

BIO Patient & Health Advocacy Summit Concludes Today

Each year BIO brings the patient stakeholder community together for the BIO Patient and Health …

2018 BIO Investor Forum Wraps Up

As the stock market continued its volatile swings this week, investors at the BIO Investor …

Innovation Intersecting with Investing – Welcome to the BIO Investor Forum

Today marks the 17th opening of the BIO Investor Forum—a place where emerging biotech companies, …

Trump’s Drug Pricing Blueprint to be Explored at Upcoming Summit

In just a few short weeks, BIO will host its annual Patient and Health Advocacy …

Delivering Innovative Medicines to Patients

Over the past two years, I lost both my father and my brother to cancer. …

Bull Market Bodes Well for #BIF18

The rapid pace of scientific discovery, FDA approvals, commercialization of medicines held long in pipelines, …

The Patient Perspective-Valuable for Drug Development

Congress, the Food and Drug Administration (FDA), drug developers, researchers and patient groups have all …